Namal Nawana (born 1970/1971) is an Australian businessman, and former chief executive (CEO) of Smith & Nephew plc, a British multinational medical equipment manufacturing company.
Namal Nawana | |
|---|---|
| Born | 1970 or 1971 (age 53–54)[1] |
| Nationality | Australian |
| Education | University of Adelaide Henley Business School |
| Occupation | Businessman |
| Title | CEO, Smith & Nephew |
| Term | May 2018-Oct 2019 |
| Predecessor | Olivier Bohuon |
| Successor | Roland Diggelmann |
Early life
editNawana earned a bachelor's degree in Mechanical Engineering in 1992, and a Masters of Medical Science from the University of Adelaide in South Australia in 1995, and an MBA from the Henley Business School, UK, in 2000.[1]
Career
editNawana was CEO of the medical diagnostics company Alere, from 2014 until April 2018, overseeing its 2017 sale to Abbott Laboratories. Subsequently, he took over from Olivier Bohuon as CEO of Smith & Nephew.[2][3] In October 2019, Smith & Nephew announced Nawana would stand down, reportedly "because his requests for higher pay, in line with the packages awarded by US medical device-makers, could not be met under UK corporate governance standards".[4]
References
edit- ^ a b "Executive Profile: Namal Nawana". Bloomberg LP. Retrieved 3 October 2018.
- ^ "Namal Nawana appointed Chief Executive Officer of Smith & Nephew - Smith & Nephew". www.smith-nephew.com. Retrieved 3 October 2018.
- ^ Dyrda, Laura. "Meet Smith & Nephew's new CEO Namal Nawana — 4 things to know". beckersspine.com. Retrieved 3 October 2018.
- ^ Kollewe, Julia (21 October 2019). "Smith & Nephew chief executive to stand down after pay row". The Guardian. Retrieved 28 October 2019.